Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics, necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens.
This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field.
This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.
About the Author: Dr. Neeraj Jain is a vice-chairman at the Rheumatology and Clinical Immunology Department at Sir Ganga Ram Hospital, New Delhi, India. He is a Professor of GRIPMER, an academic body of Sir Ganga Ram Hospital.
He did his Rheumatology training at King Edward Memorial Hospital, Mumbai, India, and Royal National Hospital for Rheumatic Diseases, BATH, UK.
He is a fellow of the Royal College of Physicians of Edinburgh (FRCP), UK, and the American College of Rheumatology (FACR).He is faculty in the Rheumatology and Clinical Immunology department at Sir Ganga Ram Hospital, established in 2009.
Dr. Neeraj has more than 30 publications to his credit in both national and international journals. He has contributed several chapters to various books and has peer-reviewed articles in many international rheumatology journals.
He is an active member of the Indian Rheumatology Association (IRA) and Delhi Rheumatology Association. He is a member of the Delhi Rheumatology and Immunology Foundation (DRIF).
Dr. Lalit Duggal is a Chairman at Rheumatology and Clinical Immunology department at Sir Ganga Ram Hospital, New Delhi, India. He is a graduate from Armed Forces Medical College Pune and completed his post-graduation in Medicine from King George's Medical College Lucknow. He has received Rheumatology training in the USA. Dr. Duggal has been a temporary advisor to the WHO since 1999.
He has been an active rheumatologist for close to three decades. He is an examiner for the NBE for the formative assessment as well as the main DNB program.
He has published several papers in many national and international journals, including original work in ankle arthritis with mediastinal lymphadenopathy and IgG4 related disease. He has contributed several chapters to various books and has peer-reviewed articles in many international rheumatology journals. He is an active member and past president of the Delhi Rheumatology Association. He is the founder and president of the Delhi Rheumatology and Immunology Foundation (DRIF).
